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Abstract
In Latin America and the Caribbean, around 195 million people live in poverty, a situation that increases the burden of some
infectious diseases. Neglected diseases, in particular, are often restricted to poor, marginalized sections of the population.
Tools exist to combat these diseases, making it imperative to work towards their elimination. In 2009, the Pan American
Health Organization (PAHO) received a mandate to support the countries in the Region in eliminating neglected diseases
and other poverty-related infections. The objective of this study is to analyze the presence of selected diseases using geo-
processing techniques. Five diseases with information available at the first sub-national level (states) were mapped, showing
the presence of the disease (‘‘hotspots’’) and overlap of diseases (‘‘major hotspots’’). In the 45 countries/territories
(approximately 570 states) of the Region, there is: lymphatic filariasis in four countries (29 states), onchocerciasis in six
countries (25 states), schistosomiasis in four countries (39 states), trachoma in three countries (29 states), and human rabies
transmitted by dogs in ten countries (20 states). Of the 108 states with one or more of the selected diseases, 36 states
present the diseases in overlapping areas (‘‘major hotspots’’). Additional information about soil-transmitted helminths was
included. The analysis suggests a majority of the selected diseases are not widespread and can be considered part of an
unfinished agenda with elimination as a goal. Integrated plans and a comprehensive approach, ensuring access to existing
diagnostic and treatment methods, and establishing a multi-sectoral agenda that addresses social determinants, including
access to adequate water and sanitation, are required. Future studies can include additional diseases, socio-economic and
environmental variables.
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Introduction
Of the 580 million people who live in Latin America and the
Caribbean, around 195 million live in poverty (defined as earning
less than two dollars a day), and 71 million live in extreme poverty
(defined as earning less than one dollar per day) [1]. Most of them,
including indigenous populations, rural poor, slum residents,
migrant workers, the elderly, and women and children, live in
unfavorable conditions and suffer a greater burden of infectious
diseases [2].
The higher burden of parasitic and other diseases could be
related to insufficient access to drinking water, sanitation,
inadequate housing, education, and health services [3,4]. Most
of these diseases cause chronic conditions that can reduce learning
capabilities, productivity, and income earning capacity. Thus,
these neglected diseases are both a cause and a consequence of
poverty [5].
The availability of new tools, the improvement of health service
infrastructure, and the implementation of new strategies—
particularly rising emphasis on primary care—make it feasible to
control and eliminate selected diseases. The elimination and
eradication of diseases has been the topic of several conferences,
workshops, and publications over the past two decades [6–9].
Some of the diseases listed as potential targets for elimination are
also included in World Health Organization’s (WHO) 2008–2015
Global Plan to Combat Neglected Tropical Diseases such as
onchocerciasis and lymphatic filariasis [2].
The Region of the Americas has successfully implemented
elimination and eradication strategies for diseases such as
smallpox, polio, and measles [10]. The countries have also
expressed political commitment to addressing poverty-related
disease elimination. They have approved various WHO and
PAHO resolutions on neglected diseases such as Chagas Disease,
onchocerciasis, congenital syphilis, leprosy and others [11–17].
Recently, PAHO’s Directing Council approved a resolution on
‘‘Elimination of Neglected Diseases and other Poverty-related
Infections’’ which reinforced the countries’ and the Organization’s
commitment to combating diseases affecting neglected populations
using integrated plans and comprehensive approaches [18].
This resolution identified twelve target diseases, which were
selected by several criteria such as being part of the unfinished
agenda, technical feasibility, and regional evidence of achievable
elimination among others. The selected diseases were divided into
two groups–those with greater potential for being eliminated, and
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1 includes diseases that have a greater potential for being
eliminated: ‘Chagas’ disease (vector-borne and transfusional
transmission, both as a public health problem); congenital syphilis
(as a public health problem); lymphatic filariasis (as a public
health problem); onchocerciasis; rabies transmitted by dogs;
neonatal tetanus (as a public health problem); trachoma (as a
public health problem); leprosy (as a public health problem at the
national and first subnational level); malaria (elimination in Haiti
and the Dominican Republic and in Mexico and Central
America); plague (as a public health problem). Group 2
encompasses diseases whose burden can be drastically reduced
with available tools: schistosomiasis and soil-transmitted helmin-
thiasis. Elimination was defined in this Resolution as the
reduction to zero of the incidence of a given disease in a defined
geographic area as a result of deliberate efforts, with continued
intervention measures being required, while elimination of a
disease as a public health problem was defined as drastically
reducing the disease’s burden to a level that is acceptable given
the current tools available and the health situation, such that, the
prevalence of the disease does not constrain social productivity
nor community development. Achievable goals were established
for each disease [18].
Among the twelve selected diseases, five have disaggregated
data available for all countries/territories of Latin America and
the Caribbean and were therefore the focus of this study,
complemented by a sixth disease with partial information.
The purpose of this paper is to present a set of epidemiological
information available on the geographic presence of the selected
diseases to support decision makers in their efforts to meet the
commitment of eliminating these diseases from the Region. This
analysis allows for the identification of the presence of the diseases
at the country and first sub-national levels, visualizing areas where
they overlap, that can be used in interprogrammatic and
intersectoral approaches, as well as taking into account potential
for cross-border activities. No effort has been conducted in the past
to map the presence and overlap of these diseases, using
standardized indicators, for all of Latin America and the
Caribbean.
Methods
Selected diseases and data
Five of the twelve diseases in the PAHO resolution cited above –
lymphatic filariasis, onchocerciasis, human rabies transmitted by
dogs, schistosomiasis, and trachoma – had data available
disaggregated at the first sub-national level at the time of this
study. These five diseases are reviewed in this article including
individual maps presenting the critical areas for intervention
(‘‘hotspots’’) by disease and the overlapping of disease maps in
order to identify ‘‘major hotspots’’ as targets for possible
interprogrammatic and intersectoral interventions by the coun-
tries. Various definitions of ‘‘hotspot’’ were reviewed to create the
definitions used in this study [19–21]. As the diseases in this article
have already been targeted for elimination, any presence is
considered a ‘‘hotspot’’ while overlapping presence is considered
even more critical as a ‘‘major hotspot.’’
There are 45 countries and territories in Latin America and the
Caribbean, with around 570 first sub-national level units within
the countries. These could be a state, department, or province
according to the administrative geopolitical units in the countries
and territories. All countries/territories and states in the Region of
the Americas are included in this analysis.
Only secondary sources of information were used, primarily
information that has been published or uploaded to the websites of
the respective Ministries of Health or of organizations that have
mandates for technical cooperation on the subject (PAHO, WHO,
and the Onchocerciasis Elimination Program for the Americas,
O E P A ) .F o rd i s e a s e sf o rw h i c ht h i si n f o r m a t i o nw a sn o ta v a i l a b l eo n
the official websites, other sources of information were used, such as
publications, reports from Regional or sub-regional plans, and
presentations from technical/scientific meetings organized by
PAHO/WHO, which were provided by the PAHO Regional
Advisors on the subjects. A preliminary document was prepared
with the same information used in this study and was uploaded to
PAHO’s website, allowing the countries to send in comments and
validate the included information [22]. This document, with over 100
references, is used as the primary source of information for the
analysis conducted in this paper.
For rabies, onchocerciasis, and lymphatic filariasis, the criteria used
was evidence of the presence of the disease over a three year period
(2005 to 2007) because the epidemiological situation may vary in a
short period of time and elimination programs are in place with
updated information for most areas. For trachoma and schistosomi-
asis, the epidemiological situation usually does not vary in short
p e r i o d sa n dt h e r ei sal a c ko fp e r i o d ic information for many countries;
t hep re se nc eoft hed ise a seisba se do ns urv ey sco n d uct e dov eralo n ge r
interval of years.For this reason, the criterion used was evidence of the
presence of the disease over the 10 year period between 1998 to 2007.
A database was created with the information obtained at the first sub-
national level and this data was utilized for geo-processing.
In the case of the soil-transmitted helminthiases (STH) Ascaris
lumbricoides, Trichuris trichiura and hookworms (Ancylostoma duodenale,
and Necator americanus), which were targeted for drastic reduction
by the Resolution, information was not available for all countries/
territories but only for some geopolitical units. Given these
circumstances and their public health importance, a separate
analysis was carried out. PAHO did an extensive literature search
to compile published data on prevalence and intensity of infection
throughout the Region during the period 1998 to 2007, and built a
database with data on prevalence of infection which included
information on 526 studies. However, most of the studies were
localized point prevalence studies covering a broad range in the
number of people surveyed, in the target age groups for the
Author Summary
Neglected diseases are often restricted to poor, margin-
alized sections of the population. Tools exist to combat
these diseases, making it imperative to work towards
their elimination. In 2009, the Pan American Health
Organization received a mandate to support the coun-
tries in the Region in eliminating neglected diseases and
other poverty-related infections. This study analyzed the
presence of selected diseases using geo-processing
techniques. Five diseases (lymphatic filariasis, onchocer-
ciasis, schistosomiasis, trachoma and human rabies
transmitted by dogs) were mapped by state, showing
the presence of the disease (‘‘hotspots’’) and overlap of
diseases (‘‘major hotspots’’). Additional information about
soil-transmitted helminths was included. In the 45
countries/territories (approximately 570 states) of the
Region, there are 108 states with one or more of the
selected diseases, and 36 states present the diseases in
overlapping areas (‘‘major hotspots’’). Integrated plans
and a comprehensive approach, ensuring access to
existing diagnostic and treatment methods, and estab-
lishing a multi-sectoral agenda that addresses social
determinants, are required.
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Country and territories Disease
Lymphatic
filariasis Onchocerciasis
Human Rabies
transmitted by dogs Schistosomiasis Trachoma
Anguilla - - - - -
Antigua and Barbuda - - - - -
Argentina - - - - -
Aruba - - - - -
Bahamas - - - - -
Barbados - - - - -
Belize - - - - -
Bolivia - - X - -
Brazil X X X X X
Cayman Islands - - - - -
Chile - - - - -
Colombia - X X - -
Costa Rica - - - - -
Cuba - - X - -
Dominica - - - - -
Dominican Republic X - - - -
Ecuador - X - - -
El Salvador - - X - -
French Guiana - - - - -
Grenada - - - - -
Guadeloupe - - - - -
Guatemala - X X - X
Guyana X - - - -
Haiti X - X - -
Honduras - - - - -
Jamaica - - - - -
Martinique - - - - -
Mexico - X X - X
Montserrat - - - - -
Netherlands Antilles - - - - -
Nicaragua - - - - -
Panama - - - - -
Paraguay - - - - -
Peru - - X - -
Puerto Rico - - - - -
Saint Kitts and Nevis - - - - -
Saint Lucia - - - X -
Saint Vincent and the Grenadines - - - - -
Suriname - - - X -
Trinidad and Tobago - - - - -
Turks and Caicos Islands - - - - -
Uruguay - - - - -
Virgin Islands (UK) - - - - -
Virgin Islands (USA) - - - - -
Venezuela - X X X -
Total number countries with evidence of the diseases 4/45 6/45 10/45 4/45 3/45
Total number first-sub national level with evidence
of the diseases
29/570 25/570 20/570 39/570 29/570
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targeted, as well as in the epidemiological and laboratory methods
for assessing prevalence of infection. To minimize the statistical
errors, the 95% confidence intervals for all of the prevalence
studies found were calculated. Given this information, states were
divided into those with a prevalence equal to or greater than 20%
in school-age children and those below that threshold.
Cartography and geo-processing
The cartography was made available by PAHO’s Health
Analysis and Information Project (HSD/HA), which compiled
data from a range of different sources, including the WHO
Evidence, Information, and Research Project (EIR) First Admin-
istrative Level Boundaries dataset (EIP_1admin, Version 1) and
the digital cartography provided by the countries’ health
Table 2. Goals and primary strategies by selected disease.
Disease Goals Primary strategies
Lymphatic filariasis – To eliminate the disease as a public health problem
(less than 1% prevalence of microfilaria in adults in sentinel
sites and spot-check sites in the area).
– Interrupt its transmission (no children between ages 2 and
4 are antigen-positive).
– To prevent and control disability.
– Mass drug administration once a year for at least 5 years with
coverage of no less than 75% or consumption of
diethylcarbamazine-fortified table salt in the daily diet.
– Surveillance of LF morbidity by local health surveillance systems.
– Morbidity case management.
– Integration/coordination of MDA with others strategies.
– Communication strategies and education in schools.
Onchocerciasis – To eliminate ocular morbidity and to interrupt transmission. – Mass drug treatment administration at least twice a year in order
to reach at least 85% of the eligible population in each endemic
area.
– Surveillance for signs of ocular morbidity, microfilaria, nodules.
– Dermatological care through the primary health care system in
areas where skin infection is a problem.
Schistosomiasis – To reduce prevalence and parasite load in high transmission
areas to less than 10% prevalence as measured by quantitative
egg counts.
– Preventive chemotherapy for at least 75% of school-age children
that live in at-risk areas, defined by a prevalence over 10% in
school-age children.
– Improvements of excreta disposal systems and access to drinking
water, education.
Human rabies
transmitted by dogs
– To eliminate human rabies transmitted by dogs (zero cases
reported to the Epidemiological Surveillance System for Rabies
(SIRVERA) coordinated by PAHO).
– Vaccination of 80% of the canine population in endemic areas.
– Care given to 100% of the exposed population at risk with post-
exposure prophylaxis when indicated.
– Epidemiological surveillance.
– Education and communication to increase awareness of the risk
of rabies.
Trachoma – To eliminate new cases of blindness caused by trachoma
(reduction in the prevalence of trachomatous trichiasis to
less than 1 case per 1,000 (general population) and reduction
in the prevalence of follicular or inflammatory trachoma
(FT and IT) to less than 5% in children aged 1-9 years).
– The ‘‘SAFE’’ strategy is used with the following components:
N To prevent blindness through eyelid surgery to correct the
inversion or entropy of the upper eyelid and trichiasis.
N To reduce the transmission in endemic areas by washing of the
face and by using antibiotics.
Soil-transmitted
helminths
- To reduce prevalence among school-age children in
high risk areas (prevalence .50%) to less than ,20%
prevalence as measured by quantitative egg count.
– Regular administration of preventive chemotherapy/or mass
drug administration (MDA) for at least 75% of school-age children
at risk, as defined by the countries considering the prevalence. If
prevalence of any soil-transmitted helminthiasis infection among
school-age children is $50% (high-risk community), treat all
school-age children twice each year. If prevalence of any soil-
transmitted helminthiasis infection among at-risk school-age
children is $20% and ,50% (low-risk community), treat all school-
age children once each year.
- Promoting access to safe water, sanitation and health education,
through intersectoral collaboration.
doi:10.1371/journal.pntd.0000964.t002
Table 1. Cont.
- No evidence
*Criteria:
Lymphatic filariasis: Evidence of the disease in the last 3 years (2005-2007)
Onchocerciasis: Evidence of the disease in the last 3 years (2005-2007)
Rabies transmitted by dogs: Evidence of the disease in the last 3 years (2006-2008)
Schistosomiasis: Evidence of the disease in the last 10 years (1998-2007)
Trachoma: Evidence of the disease in the last 10 years (1998-2007)
PAHO/HSD/CD. Epidemiological Profiles of Neglected Diseases and Other Infections Related to Poverty in Latin America and the Caribbean. Presented at the
Consultation on a Latin American and Caribbean Trust Fund for the Prevention, Control and Elimination of Neglected and Other Infectious Diseases. Washington, DC,
15-16 December 2008. Available at: http://new.paho.org/hq/index.php?option=com_joomlabook&Itemid=259&task=display&id=37.
doi:10.1371/journal.pntd.0000964.t001
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standardized the sub-national administrative units according to
WHO coding schemes [23].
For this study, several geo-processing techniques were used,
including geo-coding the selected diseases’ statistical databases,
applying specific cartographic projections to the Regional and
national levels, performing spatial queries to assemble the
choropleth mapping classification schemes on the different
geographic analysis units, and generating new dicothomic
variables in order to identify spatial distribution patterns, as well
as the geographic overlap of neglected diseases. The geo-
processing and spatial analyses were performed in the Geographic
Information Systems (GIS) software ArcView 3.3.
Results
There is evidence of the presence of selected diseases analyzed
in this study in a limited number of countries of the Americas and
for most of these countries, the presence is limited to specific first-
sub-national level units (Table 1). The information indicates that
108 (19%) of 570 first-sub-national level units have one or more of
the selected neglected diseases, thus they may be considered
‘‘hotspots’’ in the Region or critical areas for intervention. More
detailed information by disease and the overlapping ‘‘major
hotspots’’ can be found below. In addition, the goals and primary
strategies approved by PAHO’s Directing Council for the selected
diseases are included in Table 2 [18].
Lymphatic filariasis
T h e r ei se v i d e n c eo ff o c iw i t ha c t i v et r a n s m i s s i o no fl y m p h a t i c
filariasis in four countries: Brazil, Dominican Republic, Guyana, and
Haiti. It is estimated that up to 11 million people are still at-risk of
infection. The greatest population at-risk is in Haiti distributed among
all first sub-national units. In Guyana, all first sub-national level units
show evidence of the disease. In Brazil, there are foci in only one state
(Pernambuco). There are 29 of approximately 570 administrative
u n i t sa tt h ef i r s ts u b - n a t i o n a ll e v el that show evidence of lymphatic
filariasis (Figure 1). Interventions are underway in each country.
Onchocerciasis
Of 570 administrative units at the first sub-national 25 showed
evidence of the disease during the period covered by the study
(Figure 2). Onchocerciasis is focalized in 13 foci in 6 countries:
Brazil, Colombia, Ecuador, Guatemala, Mexico and Venezuela. It
is estimated that approximately 500,000 people are at-risk in the
Region. Most of these foci share state or international border. In
Venezuela, foci extend along 11 states, with the population most
Figure 1. Presence of lymphatic filariasis at the first subnational level, Latin America and the Caribbean, 2005–2007. Source: PAHO
based on reports submitted by the Ministries of Health to PAHO/WHO Program for the Elimination of Lymphatic Filariasis.
doi:10.1371/journal.pntd.0000964.g001
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indigenous populations such as the Yanomami in the Amazon
region of Brazil and Venezuela, the Mayas and other indigenous
groups in Guatemala and Mexico, and those of African descent,
who live in rural or mountainous areas [24].
By the end of 2007, transmission had been interrupted following
sustained massive treatment at least twice a year in 6 foci, 1 in
Colombia, 3 in Guatemala and 2 in Mexico. In order to certify
elimination, these foci will be under surveillance for at least 3
years, which is the criterion set by the World Health Organization.
There have been no new cases of blindness caused by
onchocerciasis in the Region since 1995.
Schistosomiasis
The disease is present in four countries in the Region: Brazil, St.
Lucia, Suriname and Venezuela (Figure 3). A study suggests that
the disease has been eliminated in previously endemic Martinique
and Guadeloupe.
25 In previous decades, the disease was known to
exist in Puerto Rico and the Dominican Republic. However, no
evidence of its presence has been found for the past 10 years,
which suggests that an epidemiological study is needed to confirm
elimination. Thirty nine of the 570 administrative units at the first
sub-national level show presence of the disease. It is estimated that
around 25 million people live at-risk in the Americas, and around
1 to 3 million people are estimated to be infected. In the
Caribbean, the incidence of schistosomiasis has been dramatically
reduced, making it possible for the disease to be eliminated (e.g.
the French territories) [25]. The current status of schistosomiasis in
Saint Lucia will be determined in a forthcoming planned study.
Human rabies transmitted by dogs
One or more cases of human rabies transmitted by dogs have
been reported in 10 countries: Bolivia, Brazil, Colombia, Cuba, El
Salvador, Guatemala, Haiti, Mexico, Peru and Venezuela.
Twenty administrative units of 570 present evidence of the disease
(Figure 4). Around 60 millions people live in these states. The
majority of the cases occur in the poor, outlying neighborhoods of
large cities, mostly in Haiti and Bolivia [26]. Cases of human and
canine rabies have been reduced by nearly 90% over the past 20
years since the inception of a Regional elimination program [27].
Even though the number of human cases is low due to country
efforts (14 cases in 2007), the number of people who live in risk
areas is still high because the virus circulation in the dog
population.
Figure 2. Presence of onchocerciasis at the first subnational level, Latin America and the Caribbean, 2005–2007. Source: PAHO based
on data from: Onchocerciasis Elimination Program for the Americas (OEPA).
doi:10.1371/journal.pntd.0000964.g002
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There is evidence of the disease in three countries: Mexico,
Guatemala and Brazil (Figure 5). Twenty-nine administrative units
of 570 present evidence of the disease. It is estimated that around
50 million people live in risk areas and about 7,000 cases have
been identified, most of them in Brazil. In Mexico, the disease is
limited to 5 municipalities in one state (Chiapas) with low
socioeconomic levels where it is primarily encountered in
indigenous populations. In Guatemala, trachoma has been
reported in 92 communities in two states. Due to the efforts of
the Trachoma Prevention and Control Program, Chiapas, Mexico
is close to eliminating the disease. Brazil has a national trachoma
control program that is carrying out an active search for cases, and
Guatemala is preparing a survey.
Soil-transmitted helminths
Soil-transmitted helminths have been present in all the countries of
the Region during the 10 year period covered by this study. Only 8 of
35 countries completed national level parasitological surveys
(principally prevalence studies) for STH occurring between 2002
and 2006, with the following prevalence ranges at the first
administrative level: Argentina 9.0–38.7%; Belize: 43.6–52.2%;
Brazil: 2–36%, Haiti: 15–87%; Honduras: 12.2–97%, Me ´xico:
0.01–16.3%, Nicaragua 27–80% and Venezuela: 3–19%. For the
other countries included in this study, the following prevalence ranges
were found according to a varying number of widely heterogenous
point-prevalence studies: Bolivia: 4.5–65.4%, Colombia: 10.7–
49.3%, Cuba: 4.5–47.3%, Dominican Republic: 5.3–55.3%; Ecua-
dor: 28.5–71%, Guatemala: 12.7–68%, Guyana: 12.3–38%, Peru:
1.8–80.4%, Saint Lucia: 35–45%, Suriname: 36–43%. Figure 6
shows the mapping of STH in 14 countries in the Region with
presence of at least one of the other five diseases included in the study
[22], according to the available information. As shown in the map,
important gaps of information on STH prevalence of infection at the
first subnational level and below exist throughout the region.
Overlapping diseases analysis
T h e r ea r e6 6s t a t e sw i t ht h ep r e s e n c eo fo n eo ft h es e l e c t e d
diseases, 33 states with the presence of two of the diseases, two
states present three of the five diseases and only one state has
evidence of the presence of four of the five selected neglected
diseases, classifying these overlapping areas as the ‘‘major
hotspots’’ (Figure 7). The combination of diseases that overlap
varies according to the country: for Brazil the greatest overlap is
Figure 3. Presence of schistosomiasis at the first subnational level, Latin America and the Caribbean, 1998–2007. Source: PAHO based
on several sources.
doi:10.1371/journal.pntd.0000964.g003
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filariasis with human rabies transmitted by dogs; and in
Venezuela it is schistosomiasis with onchocerciasis. While it is
believed that soil-transmitted helminths are present, to a varying
e x t e n t ,i nm o s to ft h ef i r s ts u b n a t ional administrative levels,
STH were not included in the overlapping analysis given that
this information is only available for some geopolitical units in
selected countries.
Discussion
This analysis suggests that the goal of elimination as a public
health problem or drastic reduction of the selected neglected
diseases is achievable in the Region. The focality of most of the
neglected diseases and the countries’ efforts, supported by
international organizations and donors, present a positive scenario
for combating neglected diseases in the Americas.
This is also the trend in the WHO South-East Asia Region,
where conditions are now in place to eliminate some of the
neglected diseases. The most important challenge will be
continued good surveillance to determine whether these diseases
remain in previously endemic areas and continued advocacy to
sustain the political commitment [28].
Determined efforts are essential to advance towards the
elimination of these poverty-related diseases and to reduce the
social burden and inequality they produce. The fight against
neglected diseases is one of the greatest challenges in achieving the
Millennium Development Goals related to reducing infectious
diseases (MDG 6) and reducing poverty (MDG 1). The recent
increase in global donor support to fight neglected diseases and
other poverty-related illnesses is expected to invigorate ongoing
initiatives at the country level [29].
The study also suggests that most of these diseases could be
considered part of the unfinished agenda for the Americas Region
— diseases that have already been identified as priority targets for
elimination and which, despite progress and the availability of
cost-effective public health intervention measures (‘tool-ready’’
diseases), have lagged behind set goals. Some exceptions could be
suggested for three of the five PAHO priority countries – defined
as countries singled out for special attention due to the fact that
their health status remains below regional averages [30]. In Haiti
and Guyana, lymphatic filariasis is present in all first sub-national
level units; in Bolivia and Haiti, rabies is present in almost half of
the states. Besides soil-transmitted helminthiases, there was no
evidence of any of the other five diseases studied in Honduras or
Nicaragua, the other two PAHO priority countries. Further
Figure 4. Presence of dog-transmitted human rabies cases at the first subnational level, Latin America and the Caribbean, 2005–
2007. Source: PAHO based on SIRVERA Database, PAHO/PANAFTOSA.
doi:10.1371/journal.pntd.0000964.g004
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the selected diseases are not present.
In the area of work towards the elimination of onchocerciasis, it
is important to mention the Onchocerciasis Elimination Program
for the Americas (OEPA). This program is a multiagency and
multinational, public-private partnership established in 1991 with
the goal of eliminating all forms of clinical disease and interrupting
disease transmission [31]. The strategy of OEPA has been, since its
inception, to provide mass drug administration (MDA) to the
eligible population in the Americas twice a year with a coverage
rate of at least 85% in each treatment round during 10–12 years -
the estimated life span of the adult parasite - complemented with
health education, social mobilization and community participa-
tion. The program has been very successful, achieving by the end
of 2009, the interruption of transmission in 7 of the 13 foci in the
region, located in 4 countries, 3 in Guatemala, 2 in Mexico, and in
each of the single foci in Colombia and Ecuador [32].
Schistosomiasis is another disease that requires additional
surveys, particularly in the Caribbean, where there is currently
only evidence of the presence of the disease in Saint Lucia and
some coastal areas of Suriname. The study done in Martinique
and Guadeloupe suggests that the disease has been eliminated
from previously endemic areas in those territories [25]. However,
there needs to be confirmation of the absence of schistosomiasis in
other countries in the Caribbean, such as in the Dominican
Republic, where the disease was formerly present and no studies
were found from the past 10 years reporting the presence or
absence of the disease.
Trachoma is present in almost all of the Brazilian states.
Therefore, surveys of bordering areas in neighboring countries will
be important in order to confirm that the disease is not present in
other countries of the Region. Additionally, the countries’
methodologies to measure trachoma could be reviewed to ensure
that all are measuring the presence of the disease with the same
criteria. For diseases with chronic symptoms, such as trachoma,
prevalence is more difficult to measure, and the surveys that are
required to estimate the burden of disease are often complex to
conduct.
Human rabies, on the other hand, is a disease with easily
identifiable symptoms. A regional notification system has been in
place for several decades with information available on all
countries. Human cases are reported by sub-national level, which
helps to define the critical areas for intervention. In this case, any
foci of human rabies transmitted by dogs are considered
‘‘hotspots’’ because the disease is no longer considered as a public
health problem in the Americas [33]. However, even with the
Figure 5. Presence of trachoma at the first subnational level, Latin America and the Caribbean, 1998–2007. Source: PAHO based on
several sources.
doi:10.1371/journal.pntd.0000964.g005
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of the elimination goal will require continued support of major
strategies such as human post-exposure prophylaxis, dog vaccina-
tion in the risk areas and surveillance.
The data on STH are very limited in that many of the available
studies were at least 5 years old and most of them were
circumscribed to very small geographic areas or to certain
populations and their results could therefore not be extrapolated
to other administrative levels. Thus, most of the countries in the
Region are in need of mapping or re-mapping to complete and
update the information on STH prevalence and report intensity of
infection. Brazil will start in 2010 a national survey to update the
epidemiological information on STH and schistosomiasis.
The overlapping analysis in this study indicates there are many
sub-national units with more than one of the five selected diseases,
suggesting that theseareas could be considered ‘‘majorhotspots’’ for
integrated and intersectoral country approaches tackling the social
determinantsofhealthinadditiontomedicalcareofpeoplewiththe
diseases. Identifying hotspots at the first sub-national level is useful
at the national and state political levels for advocacy purposes and
for decision-makers to know the states where integrated approaches
to tackle the neglected tropical diseases might be required and
identify existing gaps and needs for information. However,
elimination programs need maps refined to a lower level of
disaggregation,downtothecommunitylevel,forproperplanningof
integrated public health and intersectoral interventions. Therefore,
further studies could be performed to identify ‘‘hotspots’’ to define
more accurate baselines, possibly including additional diseases,
socio-economic and environmental variables, and applying other
clustering and correlation spatial analysis techniques. These types of
studies could provide evidence for decision-making to establish
integrated plans with a comprehensive approach and continue the
ethical fight against neglected diseases.
In areas where overlapping of STH infections occurs either with
lymphatic filariasis, onchocerciasis and schistosomiasis, there is an
opportunity to integrate deworming for the two diseases. In fact, a
deworming drug (albendazole) is included in the recommended
combination for MDA used in the regional program to eliminate
lymphatic filariasis. Besides deworming, another opportunity to
integrate interventions to reduce the burden of several neglected
tropical diseases is improving access to both safe water supply and
adequate basic sanitation. This is critical to achieve a long-term
reduction in both the burden (intensity of infection) and prevalence
of STH in pre-school and school-age children, and also plays an
important role in reducing the burden of schistosomiasis and
lymphatic filariasis. In general in Latin America and the Caribbean,
it is basic sanitation which lags behind. Thus regional estimates of
the number of school-age children at risk of STH morbidity should
Figure 6. Prevalence of Soil-Transmitted Helminths according to existing studies, Latin America and the Caribbean, 1998–2007.
Source: PAHO based on several sources.
doi:10.1371/journal.pntd.0000964.g006
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sanitation, that is, 15% of school-age children in urban areas and
55% in rural areas. In estimated numbers, this indicates that, for
2007, 12.9 million school-age children in urban areas and 13.4
million school-age children in rural areas, a total of 26.3 million
school-age children in the LAC Region, were at high risk of
infection by STH and therefore in need periodic deworming.
According to PAHO’s database on STH, the reported coverage
reached in 2007 was 8.6 million presumably at-risk school-age
children, or 32.7% of the estimated total population of school-age
children at risk. Thus the treatment coverage gap was 17.7 million
children (67.3% unreached). Looking at coverage targets based on
the World Health Assembly Resolution 54.19 (2001) which set a
benchmark of at least 75%to 100% treatment coverage targeted for
school-age children at risk, our data indicate that coverage in the
region should have reached at least 19.7 million and up to 26.3
million children in 2007.
It should be noted that there are some limitations to this study.
One limitation is the potential for an underestimation of the
occurrence of the disease in some countries, such as is the case for
trachoma, information which is based on surveys. Additional
studies need to be developed to confirm that this disease is not
present in other areas. It is also worth pointing out that there is
variance in the capacity that countries have to accurately represent
the extent of diseases.
This analysis was conducted at the first subnational administra-
tive level. This was done because this is the best level at which these
diseases can be overlapped, given the available data. However,
limitations exist when comparing first subnational level administra-
tive units, given the considerable range of variation in terms of size
andpopulationoftheseunits.Furthermore,insome casesthe spatial
presence of the diseases may be limited to foci that are much smaller
than the entire state which has been marked as affected, as can be
seen in the case of onchocerciasis. A similar limitation could be said
of the information available on schistosomiasis in Southern as well
as part of Southeastern Brazil, where the disease occurs but possibly
at rates lower than the targets proposed in Table 2. Therefore, in
some cases, this might lead to a visual overestimation of the
dissemination of a disease. Also limitations exist when comparing
first subnational level administrative units, given the considerable
range of variation in terms of size and population of these units
among the countries in the Region.
The possibility of overestimating the relevance of some diseases
in countries with better surveillance systems as compared to other
countries in the Region, mostly for diseases that need periodic
surveys to be estimated, also exists.
Figure 7. Overlapping diseases present in the country at the first subnational level, Latin America and the Caribbean. Source: PAHO,
based on several sources.
doi:10.1371/journal.pntd.0000964.g007
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the overlapping study, other neglected diseases present throughout
the Region – such as soil-transmitted helminthiasis, Chagas
Diseases, congenital syphilis, and plague – must be considered
once further epidemiological data is collected and incorporated
into possible integrated approaches.
In the review of the literature, no other effort was found to have
taken on the endeavor of mapping, for the entire region of Latin
America and the Caribbean, these selected neglected diseases, as
opposed to mapping one disease or country at a time.
The diseases highlighted in this study disproportionately affect
vulnerable populations. In fact, several of the selected diseases –
lymphatic filariasis, onchocerciasis, and schistosomiasis – were
most likely imported to the Western Hemisphere through the slave
trade and persist in the region as historical legacies of slavery [34].
The presence of these diseases can be considered as a social debt to
the affected population and therefore, identified as priority areas
for intervention.
Finally, the public health strategies that are used to eliminate or
reduce diseases to acceptable levels go beyond routine control
measures. In order to strengthen the efforts against diseases related
to poverty as a group, countries and territories in the Region could
develop integrated plans under the same framework. Plans and
guidelines are already available to eliminate or control the selected
diseases, as are tools such as drugs and diagnostic techniques to
support surveillance systems. For these diseases to be eliminated,
emphasis should be placed at the country level on evidence-based
decisions for strengthening health surveillance systems, mapping
the diseases to identify remaining ‘‘hotspots,’’ and identification of
geopolitical areas in which the diseases overlap (‘‘major hotspots’’).
It is necessary to ensure that resources are available for the
primary care system to help reduce inequalities in the fight against
these diseases. Inter-programmatic interventions should be
established that integrate the various plans, breaking the barrier
between diseases and disciplines. Pursuing community participa-
tion and intersectoral partnerships is crucial, as involving the
community, stakeholders and all potential partners within and
outside the health sector will make actions sustainable [18].
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